These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 29957018

  • 21. Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.
    Seubwai W, Vaeteewoottacharn K, Kraiklang R, Umezawa K, Okada S, Wongkham S.
    Oncol Res; 2016 Jan 21; 23(1-2):21-8. PubMed ID: 26802647
    [Abstract] [Full Text] [Related]

  • 22. Role of salubrinal in protecting cardiomyocytes from doxorubicin-induced apoptosis.
    Gong N, Wu JH, Liang ZS, Jiang WH, Wang XW.
    Genet Mol Res; 2015 Oct 16; 14(4):12377-85. PubMed ID: 26505387
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Lovastatin-induced apoptosis is mediated by activating transcription factor 3 and enhanced in combination with salubrinal.
    Niknejad N, Gorn-Hondermann I, Ma L, Zahr S, Johnson-Obeseki S, Corsten M, Dimitroulakos J.
    Int J Cancer; 2014 Jan 15; 134(2):268-79. PubMed ID: 23824972
    [Abstract] [Full Text] [Related]

  • 26. Artesunate and chloroquine induce cytotoxic activity on cholangiocarcinoma cells via different cell death mechanisms.
    Guragain D, Seubwai W, Kobayashi D, Silsinivanit A, Vaeteewoottacharn K, Sawanyawisuth K, Wongkham C, Wongkham S, Araki N, Cha'on U.
    Cell Mol Biol (Noisy-le-grand); 2018 Jul 30; 64(10):113-118. PubMed ID: 30084802
    [Abstract] [Full Text] [Related]

  • 27. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z, Tang X, Zhang Y, Qi R, Li Z, Zhang K, Liu Z, Yang X.
    Biomed Pharmacother; 2012 Apr 30; 66(3):161-6. PubMed ID: 22425181
    [Abstract] [Full Text] [Related]

  • 28. Salubrinal, an eIF2α dephosphorylation inhibitor, enhances cisplatin-induced oxidative stress and nephrotoxicity in a mouse model.
    Wu CT, Sheu ML, Tsai KS, Chiang CK, Liu SH.
    Free Radic Biol Med; 2011 Aug 01; 51(3):671-80. PubMed ID: 21616140
    [Abstract] [Full Text] [Related]

  • 29. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.
    Wang C, Lv H, Yang W, Li T, Fang T, Lv G, Han Q, Dong L, Jiang T, Jiang B, Yang G, Wang H.
    Cancer Lett; 2017 Jul 10; 398():1-11. PubMed ID: 28385602
    [Abstract] [Full Text] [Related]

  • 30. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis.
    Kim JH, Liu L, Lee SO, Kim YT, You KR, Kim DG.
    Cancer Res; 2005 Jul 15; 65(14):6312-20. PubMed ID: 16024633
    [Abstract] [Full Text] [Related]

  • 31. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y, Zhang M, Dorfman RG, Li Y, Zhao Z, Pan Y, Zhou Q, Huang S, Zhao S, Yao Y, Zou X.
    Cell Death Dis; 2017 Jun 01; 8(6):e2856. PubMed ID: 28569784
    [Abstract] [Full Text] [Related]

  • 32. Metformin sensitizes cholangiocarcinoma cell to cisplatin-induced cytotoxicity through oxidative stress mediated mitochondrial pathway.
    Wandee J, Prawan A, Senggunprai L, Kongpetch S, Kukongviriyapan V.
    Life Sci; 2019 Jan 15; 217():155-163. PubMed ID: 30528773
    [Abstract] [Full Text] [Related]

  • 33. GSK‑3β inhibition promotes doxorubicin‑induced apoptosis in human cholangiocarcinoma cells via FAK/AKT inhibition.
    Li L, Xiang Y, Zeng Y, Xiao B, Yu W, Duan C, Xia X, Zhang T, Zeng Y, Liu Y, Dai R.
    Mol Med Rep; 2020 Nov 15; 22(5):4432-4441. PubMed ID: 33000181
    [Abstract] [Full Text] [Related]

  • 34. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U, Seubwai W, Waraasawapati S, Wongkham S, Boonmars T, Cha'on U, Wongkham C.
    Anticancer Res; 2020 Sep 15; 40(9):5115-5124. PubMed ID: 32878800
    [Abstract] [Full Text] [Related]

  • 35. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.
    Yapasert R, Lertprasertsuk N, Subhawa S, Poofery J, Sripanidkulchai B, Banjerdpongchai R.
    Int J Mol Sci; 2020 Aug 07; 21(16):. PubMed ID: 32784671
    [Abstract] [Full Text] [Related]

  • 36. MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma.
    Lampis A, Carotenuto P, Vlachogiannis G, Cascione L, Hedayat S, Burke R, Clarke P, Bosma E, Simbolo M, Scarpa A, Yu S, Cole R, Smyth E, Mateos JF, Begum R, Hezelova B, Eltahir Z, Wotherspoon A, Fotiadis N, Bali MA, Nepal C, Khan K, Stubbs M, Hahne JC, Gasparini P, Guzzardo V, Croce CM, Eccles S, Fassan M, Cunningham D, Andersen JB, Workman P, Valeri N, Braconi C.
    Gastroenterology; 2018 Mar 07; 154(4):1066-1079.e5. PubMed ID: 29113809
    [Abstract] [Full Text] [Related]

  • 37. Synergistic cytotoxicity and apoptosis induced in human cholangiocarcinoma cell lines by a combined treatment with tumor necrosis factor-alpha (TNF-alpha) and triptolide.
    Panichakul T, Wanun T, Reutrakul V, Sirisinha S.
    Asian Pac J Allergy Immunol; 2002 Sep 07; 20(3):167-73. PubMed ID: 12587840
    [Abstract] [Full Text] [Related]

  • 38. Reactive oxygen species and p38 MAPK regulate Bax translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B cells.
    Park GB, Kim YS, Lee HK, Song H, Kim S, Cho DH, Hur DY.
    Cancer Lett; 2011 Dec 27; 313(2):235-48. PubMed ID: 22056078
    [Abstract] [Full Text] [Related]

  • 39. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma.
    Asukai K, Kawamoto K, Eguchi H, Konno M, Asai A, Iwagami Y, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H.
    Ann Surg Oncol; 2017 Aug 27; 24(8):2344-2352. PubMed ID: 28560603
    [Abstract] [Full Text] [Related]

  • 40. Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
    Burchard PR, Ruffolo LI, Ullman NA, Dale BS, Dave YA, Hilty BK, Ye J, Georger M, Jewell R, Miller C, De Las Casas L, Jarolimek W, Perryman L, Byrne MM, Loria A, Marin C, Chávez Villa M, Yeh JJ, Belt BA, Linehan DC, Hernandez-Alejandro R.
    Hepatol Commun; 2024 Aug 01; 8(8):. PubMed ID: 39101793
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.